A

Aurinia (AUPH)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Aurinia (AUPH)

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in pa... Read more

Open
USD8.11
High
USD8.21
Low
USD7.93
52 Week High
USD10.67
Monthly Return
5.10%
Revenue
224M

Daily Vol.
1.51M
Avg. Daily Vol.
988.42k
Market Cap.
1.1B
52 Week Low
4.99
Annual Return
54.70%
Forward P/E
17.80%

Stock News

U.S. and China conclude two days of ‘productive’ trade talks, Bessent says

U.S. and China conclude two days of ‘productive’ trade talks, Bessent says

MarketWatch

Trump poised to accept Qatar jet gift as Air Force One

Trump poised to accept Qatar jet gift as Air Force One

CNBC

Here are the 3 things we're watching in the stock market in the week ahead

Here are the 3 things we're watching in the stock market in the week ahead

CNBC

Invesco Corporate Bond Fund Q1 2025 Commentary

Invesco Corporate Bond Fund Q1 2025 Commentary

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.